Evaluating multiple treatment courses in clinical trials.
By Peter F. Thall, R. Millikan, H. Sung. 2000
151 citations recorded by the source corpus.
Subfields: Management Science and Operations Research, Statistics and Probability
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Management Science and Operations Research
- Donglin Zeng
- Susan A. Murphy
- Rui Song
- Junzhe Zhang
- W. Wang
- Michael R. Kosorok
- Elias Bareinboim
- Marco Guerzoni
In Statistics and Probability
- Eric B. Laber
- Michael R. Kosorok
- D. Almirall
- Donglin Zeng
- Abiral Baniya
- Susan A. Murphy
- Leonard A. Stefanski
- Kristin A. Linn
Citations in the corpus
- Dynamic treatment regimes (2009, methodology): “Thall and colleagues (Thall et al. 2000, 2002, 2007) developed several likelihood based methods, both Bayesian and frequentist, for selecting the best dynamic treatment regime.”
- The International Journal of Biostatistics (2017, unknown): “The original results of Thall et al. (2000) focus on fitting logistic regression models for the different stage-specific factors of the likelihood.”
- Near-Optimal Reinforcement Learning in Dynamic Treatment Regimes (2019, background): “These decision rules are alternatively known as adaptive treatment strategies [12, 13, 19, 33, 34] or treatment policies [16, 37, 38].”
- Demystifying Optimal Dynamic Treatment Regimes (2007, unknown): “Thall et al. (2000) produced a likelihood-based approach to analyze sequentially randomized trials for optimal regimes for prostate cancer treatment, where randomization probabilities changed as information from patients accrued.”
- An experimental design for the development of adaptive treatment strategies (2005, background): “…2001), the CATIE trial for antipsychotic medications in patients with Schizophrenia (see http:// www.catie.unc.edu/schizophrenia/synopsis.html), STAR*D for treatment of depression(Rush et al., 2003; Lavori et al., 2001) and phase II trials at MD Anderson for treating cancer (Thall et al., 2000).”
- Designing a Pilot Sequential Multiple Assignment Randomized Trial for Developing an Adaptive Treatment Strategy (2012, unknown): “[22] for more recent work.”
- A Generalization Error for Q-Learning (2005, background): “For example there are currently a number of ongoing large clinical trials for chronic disorders in which, each time an individual relapses, the individual is re-randomized to one of several further treatments (Schneider et al., 2001; Fava et al., 2003; Thall et al., 2000).”
- Reinforcement learning design for cancer clinical trials (2009, unknown): “[4] provided a statistical framework for multi-course clinical trials involving some modifications of the play-the-winner-and-drop-the-loser strategy.”
- Developing adaptive treatment strategies in substance abuse research. (2007, methodology): “, 2006) along with methods that permit a greater variety of outcome variables (Thall et al., 2000) or time-to-an-event outcomes (Lunceford et al.”
- Adaptive Interventions Treatment Modelling and Regimen Optimization Using Sequential Multiple Assignment Randomized Trials (Smart) and Q-Learning (2018, background): “For this purpose, numerous literature on clinical trial design employing experimental data are present [5, 29-32, 42, 43] that defines construction of sequential multiple assignment randomized trial (SMART) where a patient is randomized more than one time through all possible treatment options at ea”
- Placebo‐free designs for evaluating new mental health treatments: the use of adaptive treatment strategies (2004, background): “Others have referred to such strategies as dynamic treatments [10] or multi-course therapies [11].”
- Demand-side vs. supply-side technology policies: Hidden treatment and new empirical evidence on the policy mix (2015, background): “The problem is very well known in clinical research, when typically various compounds are administered to patients as a cure for the same disease (Thall et al., 2000), and in the alternative medicine/integrative medicine framework, which studies the interaction of alternative and integrative medicin”